EP 1701959 A1 20060920 - TRIAZOLE DERIVATIVES AS VASOPRESSIN ANTAGONISTS
Title (en)
TRIAZOLE DERIVATIVES AS VASOPRESSIN ANTAGONISTS
Title (de)
TRIAZOLDERIVATE ALS VASOPRESSINANTAGONISTEN
Title (fr)
DÉRIVÉS DE TRIAZOLE COMME ANTAGONISTES DE VASOPRÉSSINE
Publication
Application
Priority
- IB 2004004059 W 20041209
- GB 0329693 A 20031222
- GB 0408789 A 20040420
Abstract (en)
[origin: WO2005063754A1] Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: V represents a direct link or -O-; Ring A represents an optionally substituted 5- to 7-membered saturated heterocyclic ring, or a phenylene group.
IPC 8 full level
C07D 487/04 (2006.01); A61K 31/454 (2006.01); A61P 25/00 (2006.01); C07D 401/04 (2006.01); C07D 401/14 (2006.01); C07D 405/14 (2006.01); C07D 413/14 (2006.01); C07D 471/04 (2006.01)
CPC (source: EP KR)
A61K 31/454 (2013.01 - KR); A61P 1/04 (2017.12 - EP); A61P 1/08 (2017.12 - EP); A61P 1/14 (2017.12 - EP); A61P 1/16 (2017.12 - EP); A61P 3/04 (2017.12 - EP); A61P 3/10 (2017.12 - EP); A61P 7/02 (2017.12 - EP); A61P 7/10 (2017.12 - EP); A61P 9/00 (2017.12 - EP); A61P 9/04 (2017.12 - EP); A61P 9/10 (2017.12 - EP); A61P 9/12 (2017.12 - EP); A61P 9/14 (2017.12 - EP); A61P 11/00 (2017.12 - EP); A61P 11/06 (2017.12 - EP); A61P 13/02 (2017.12 - EP); A61P 13/12 (2017.12 - EP); A61P 15/00 (2017.12 - EP); A61P 15/06 (2017.12 - EP); A61P 15/08 (2017.12 - EP); A61P 15/10 (2017.12 - EP); A61P 19/02 (2017.12 - EP); A61P 25/00 (2017.12 - EP); A61P 25/04 (2017.12 - EP); A61P 25/14 (2017.12 - EP); A61P 25/20 (2017.12 - EP); A61P 25/22 (2017.12 - EP); A61P 25/24 (2017.12 - EP); A61P 25/28 (2017.12 - EP); A61P 27/06 (2017.12 - EP); A61P 27/12 (2017.12 - EP); A61P 29/00 (2017.12 - EP); A61P 31/04 (2017.12 - EP); A61P 35/00 (2017.12 - EP); A61P 43/00 (2017.12 - EP); C07D 401/04 (2013.01 - EP); C07D 401/14 (2013.01 - EP KR); C07D 403/14 (2013.01 - KR); C07D 405/14 (2013.01 - EP); C07D 413/14 (2013.01 - EP); C07D 471/04 (2013.01 - EP)
Citation (search report)
See references of WO 2005063754A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA HR LV MK YU
DOCDB simple family (publication)
WO 2005063754 A1 20050714; AP 2006003631 A0 20060630; AP 2331 A 20111205; AR 047340 A1 20060118; AU 2004309164 A1 20050714; AU 2004309164 B2 20071115; BR PI0417267 A 20070417; CA 2551038 A1 20050714; CA 2551038 C 20100427; CR 8481 A 20071204; DO P2004001062 A 20050630; EA 010132 B1 20080630; EA 200600925 A1 20061229; EC SP066647 A 20061025; EP 1701959 A1 20060920; GE P20084571 B 20081225; HK 1095822 A1 20070706; IL 176349 A0 20061005; IL 176349 A 20111130; IS 8472 A 20060518; JP 2007515468 A 20070614; JP 4698604 B2 20110608; KR 100854872 B1 20080828; KR 20060101546 A 20060925; MA 28393 B1 20070102; NL 1027833 A1 20050623; NL 1027833 C2 20060306; NO 20063380 L 20060922; OA 13347 A 20070413; PA 8620501 A1 20050804; PE 20051051 A1 20051217; TW 200528099 A 20050901; TW I287541 B 20071001; UY 28693 A1 20050729
DOCDB simple family (application)
IB 2004004059 W 20041209; AP 2006003631 A 20041209; AR P040104826 A 20041221; AU 2004309164 A 20041209; BR PI0417267 A 20041209; CA 2551038 A 20041209; CR 8481 A 20060622; DO 2004001062 A 20041222; EA 200600925 A 20041209; EC SP066647 A 20060615; EP 04801354 A 20041209; GE AP2004009469 A 20041209; HK 07102965 A 20070320; IL 17634906 A 20060615; IS 8472 A 20060518; JP 2006546356 A 20041209; KR 20067012328 A 20060621; MA 29125 A 20060622; NL 1027833 A 20041221; NO 20063380 A 20060721; OA 1200600206 A 20041209; PA 8620501 A 20041222; PE 2005000032 A 20050103; TW 93139507 A 20041217; UY 28693 A 20041221